Release of Histamine from Dural Mast Cells by Substance P and Calcitonin Gene-Related Peptide

The aim of the present study was to examine if the neuropeptides substance P (SP), calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) can stimulate histamine release from mast cells in the dura mater and thereby play a role in cranial vasoregulation and local neurogenic inflammation. Dura mater mast cells were compared with peritoneal mast cells in the rat. Histamine was released from dura mater mast cells by compound 48/80, SP and CGRP but from peritoneal mast cells only by compound 8/80 and SP. NPY and VIP released quite small amounts of histamine from dural mast cells. The release on SP and CGRP from rat dura mater mast cells was blocked by the receptor antagonists FK888 and CGRP8-37 respectively, suggesting receptor mediated release mechanisms. None of the stimuli released histamine from human or porcine dural mast cells, possibly because the sampling procedure injures and incapacitates the cells.

[1]  G. Chrousos,et al.  Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. , 1995, Endocrinology.

[2]  P. Geppetti,et al.  Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack , 1995, Pain.

[3]  P. Goadsby,et al.  Neuropeptides in Migraine and Cluster Headache , 1994, Cephalalgia : an international journal of headache.

[4]  P. Goadsby,et al.  Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. , 1994, Brain : a journal of neurology.

[5]  R. Håkanson,et al.  Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist , 1994, British journal of pharmacology.

[6]  M. Moskowitz,et al.  Time‐dependent blockade of neurogenic plasma extravasation in dura mater by 5‐HT1B/D agonists and endopeptidase 24.11 , 1993, British journal of pharmacology.

[7]  R. Hargreaves,et al.  The non‐peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats , 1993, British journal of pharmacology.

[8]  P. Goadsby,et al.  The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats , 1993, Annals of neurology.

[9]  J. Foreman.  Immunopharmacology of mast cells and basophils , 1993 .

[10]  H. Morimoto,et al.  Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888 , 1992, British journal of pharmacology.

[11]  J. Olesen,et al.  Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries , 1992, Peptides.

[12]  M. Moskowitz,et al.  Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation , 1992, Neuroscience.

[13]  M. Moskowitz,et al.  Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells , 1991, Neuroscience.

[14]  M. Zuccarello,et al.  Influence of the Sympathetic Nervous System as Well as Trigeminal Sensory Fibres on Rat Dural Mast Cells , 1991, Cephalalgia : an international journal of headache.

[15]  J. Mcculloch,et al.  Tachykinins (Substance P, Neurokinin A, Neuropeptide K, and Neurokinin B) in the Cerebral Circulation: Vasomotor Responses in vitro and in situ , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  M. Moskowitz,et al.  Further characterization of the putative 5‐HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater , 1991, British journal of pharmacology.

[17]  M. Moskowitz.  The visceral organ brain , 1991, Neurology.

[18]  J. Arrang,et al.  Histamine and Histamine Antagonists , 1991, Handbook of Experimental Pharmacology.

[19]  M. Moskowitz.  Basic mechanisms in vascular headache. , 1990, Neurologic clinics.

[20]  P. Goadsby,et al.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache , 1990, Annals of neurology.

[21]  Makoto Sato,et al.  Histamine acts directly on calcitonin gene-related peptide- and substance P-containing trigeminal ganglion neurons as assessed by calcium influx and immunocytochemistry , 1990, Neuroscience Letters.

[22]  M. Tohyama,et al.  Histamine application to the nasal mucosa induces release of calcitonin gene-related peptide and substance P from peripheral terminals of trigeminal ganglion: A morphological study in the guinea pig , 1990, Neuroscience Letters.

[23]  T. Ishikawa,et al.  Histamine acts directly on calcitonin gene-related peptide- and substance P-containing trigeminal ganglion neurons as assessed by calcium influx and immunocytochemistry. , 1990, Auris, nasus, larynx.

[24]  R. Ekman,et al.  Capsaicin evokes secretion of nasal fluid and depletes substance P and calcitonin gene‐related peptide from the nasal mucosa in the rat , 1989, British journal of pharmacology.

[25]  M. Fukase,et al.  Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). , 1989, The American journal of physiology.

[26]  L. Edvinsson,et al.  Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. , 1989, Journal of the autonomic nervous system.

[27]  M. Moskowitz,et al.  The development of neurogenic plasma extravasation in the rat dura mater does not depend upon the degranulation of mast cells , 1989, Brain Research.

[28]  M. Moskowitz,et al.  Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches , 1988, Annals of neurology.

[29]  J. Olesen,et al.  Basic Mechanisms of Headache , 1988 .

[30]  J. Bienenstock.  An update on mast cell heterogeneity. , 1988, The Journal of allergy and clinical immunology.

[31]  M. Church,et al.  Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. , 1988, The Journal of allergy and clinical immunology.

[32]  P. Goadsby,et al.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system , 1988, Annals of neurology.

[33]  M. Moskowitz,et al.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  R. Håkanson,et al.  Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. , 1987, European journal of pharmacology.

[35]  P. Emson,et al.  Nerve Fibers Containing Neuropeptide Y in the Cerebrovascular Bed: Immunocytochemistry, Radioimmunoassay, and Vasomotor Effects , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  K. Barrett,et al.  On the heterogeneity of mast cells. , 1986, Pharmacology.

[37]  J. Foreman,et al.  Some effects of calcitonin gene‐related peptide in human skin and on histamine release , 1986, The British journal of dermatology.

[38]  J. Foreman,et al.  Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. , 1986, International archives of allergy and applied immunology.

[39]  D. Jacobowitz,et al.  Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat , 1985, Peptides.

[40]  D. Jacobowitz,et al.  Origin of cholinergic nerves to the rat major cerebral arteries: Coexistence with vasoactive intestinal polypeptide , 1985, Brain Research Bulletin.

[41]  M. Moskowitz.  The neurobiology of vascular head pain , 1984, Annals of neurology.

[42]  M. Moskowitz,et al.  Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry , 1984, The Journal of comparative neurology.

[43]  P. Emson,et al.  Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat , 1983, Neuroscience Letters.

[44]  R. Håkanson,et al.  Substance P antagonists release histamine from peritoneal mast cells. , 1983, Acta physiologica Scandinavica.

[45]  J. Foreman,et al.  Structure‐activity relationships for some substance P‐related peptides that cause wheal and flare reactions in human skin. , 1983, The Journal of physiology.

[46]  H. Steiger,et al.  The sensory representation of the dura mater in the trigeminal ganglion of the cat , 1982, Neuroscience Letters.

[47]  L. Edvinsson,et al.  Adrenergic, Cholinergic and Peptidergic Nerve Fibres in Dura Mater Involvement in Headache? , 1981, Cephalalgia : an international journal of headache.

[48]  E. Melamed,et al.  NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE? , 1979, The Lancet.

[49]  L. Edvinsson,et al.  Regional distribution of mast cells containing histamine, dopamine, or 5‐hydroxytryptamine in the mammalian brain , 1977, Neurology.

[50]  E. G. Erdös,et al.  Release of Histamine from Mast Cells by Vasoactive Peptides 1 , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[51]  L. Junqueira,et al.  Protamine-like Property of Compounds 48/80 and Stilbamidine and Their Action on Mast Cells.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.